PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Protectin DX promotes epithelial injury repair and inhibits fibroproliferation partly via ALX/PI3K signalling pathway.

Mixed / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33098250 ↗2020Reported benefit

Protectin DX promotes epithelial injury repair and inhibits fibroproliferation partly via ALX/PI3K signalling pathway.

MixedEndotoxin/LPSC57BL/6n = n = 6 per group across four groups; in vitro three independ…Intraperitoneal200 ng per mouse in 0.1 mL normal saline in vivo; 1-100 nmo…After intratracheal LPS

Model: Endotracheal injection of LPS (E. coli 055:B5) 10 mg/kg in 30 uL, assessed at 6, 24, 48 and 72 h

Protectin DX reduced lung injury score, wet/dry ratio, BALF protein and cytokines, promoted alveolar type II cell proliferation and wound repair, reduced apoptosis and suppressed TGF-beta-driven fibroproliferation.

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.